Bruins notebook: Parker Wotherspoon looking to stick in NHL
Published Fri, 21 Feb 2025 10:39:54 GMT
MCAS Miramar Marine arrested after pursuit ending in fatal crash
Published Fri, 21 Feb 2025 10:39:54 GMT
Italian fashion influencer apologizes for charity miscommunication, is fined 1 million euros
Published Fri, 21 Feb 2025 10:39:54 GMT
Thousands rally across Slovakia to protest the government’s plan to amend the penal code
Published Fri, 21 Feb 2025 10:39:54 GMT
Greece approves new law granting undocumented migrants residence rights, provided they have a job
Published Fri, 21 Feb 2025 10:39:54 GMT
Kenneth Law, man accused of selling deadly substances online, due back in court next month
Published Fri, 21 Feb 2025 10:39:54 GMT
Nevada high court upholds sex abuse charges against ‘Dances With Wolves’ actor Nathan Chasing Horse
Published Fri, 21 Feb 2025 10:39:54 GMT
Kentucky’s Democratic governor refers to Trump’s anti-immigrant language as dangerous, dehumanizing
Published Fri, 21 Feb 2025 10:39:54 GMT
New York City faulted for delays in getting emergency food aid to struggling families
Published Fri, 21 Feb 2025 10:39:54 GMT
Results in Iraqi provincial elections show low turnout and benefit established parties
Published Fri, 21 Feb 2025 10:39:54 GMT
Latest news
- Opinion: It should’t take an advanced degree to do your taxes
- Atherton police warn public of scams targeting the elderly
- Republican senator should drop his ‘irresponsible’ protest and OK military nominees, Biden says
- March Madness expansion discussed by NCAA committee but no deal imminent
- Iranian president welcomed in Zimbabwe with anti-West songs on the last stop on his Africa trip
- People treated for possible heat exhaustion, dehydration in Taylor Swift merch line
- Biden declares victory over Putin as he tries to galvanize allies at home and abroad
- India buys French fighter jets, submarines as Modi visits Macron
- Kevin Spacey fights back tears as he testifies how sex abuse allegations ‘exploded’ his career
- Patients squeezed in fight over who gets to bill for pricey infusion drugs